Lisa Ebert, Research Scientist at Centre for Cancer Biology, shared on LinkedIn:
“I’m speaking at SITC!
Very pleased to share that my abstract.
‘Tumor-homing T cells in the blood predict the efficacy of anti-PD-1 immunotherapy in melanoma patients’
has been accepted for oral presentation at Society for Immunotherapy of Cancer (SITC)’s 41st annual meeting in Phoenix, USA this November!
I’m looking forward to sharing our story about new biomarkers to predict who will benefit from immune checkpoint drugs, and new knowledge on the biological pathways underlying treatment success.”
You may also be interested in:
New Research on BOT+BAL in Metastatic Colorectal Cancer to Be Presented at SITC 2026 – Agenus